Monitoring for and Management of Endocrine Dysfunction in Adrenoleukodystrophy
Adrenoleukodystrophy (ALD) is a peroxisomal disorder affecting the nervous system, adrenal cortical function, and testicular function. Newborn screening for ALD has the potential to identify patients at high risk for life-threatening adrenal crisis and cerebral ALD. The current understanding of the...
Main Authors: | Isha Kachwala, Molly O. Regelmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/8/1/18 |
Similar Items
-
Newborn Screening for X-Linked Adrenoleukodystrophy: Past, Present, and Future
by: Ann B. Moser, et al.
Published: (2022-02-01) -
Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up
by: Jamie Matteson, et al.
Published: (2021-04-01) -
Newborn Screening for X-Linked Adrenoleukodystrophy: The Initial Illinois Experience
by: Barbara K. Burton, et al.
Published: (2022-01-01) -
ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy
by: Volmrich AM, et al.
Published: (2022-08-01) -
Adrenoleukodystrophy in the Differential Diagnosis of Boys Presenting with Primary Adrenal Insufficiency without Adrenal Antibodies
by: Michael R Ryalls, et al.
Published: (2021-06-01)